Clinical Safety Experience of TAK-003 for Dengue Fever: A New Tetravalent Live Attenuated Vaccine Candidate

BACKGROUND: An unmet medical need remains for an effective dengue tetravalent vaccine that can be administered irrespective of previous dengue exposure. TAK-003, a dengue tetravalent vaccine, has demonstrated efficacy in an ongoing phase 3 trial in children and adolescents living in dengue-endemic a...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Sanjay S, Rauscher, Martina, Kudela, Maria, Pang, Hang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907483/
https://www.ncbi.nlm.nih.gov/pubmed/35639602
http://dx.doi.org/10.1093/cid/ciac418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907483/
https://www.ncbi.nlm.nih.gov/pubmed/35639602
http://dx.doi.org/10.1093/cid/ciac418

Ejemplares similares